However, the wide expression of SSTR2 argues against antagonism for this receptor for future pharmacological development, as this may influence many systems; importantly, the Sstr2 has been found to be highly expressed in certain types of cancers (48–50). This evidence concerns the gene SSTR2 and cancer.